In pancreatic cancer, the target of hispidulin is the vascular endothelial growth factor (VEGF) receptor 2 mediated PI3K/Akt/mTOR signalling pathway in endothelial cells, thereby suppressing pancreatic tumor cell growth and angiogenesis [180]. Here, VEGFA is linked to pancreatic neoplasm.